Griffith University and Knee Research Australia.
Arthroscopy. 2021 May;37(5):1691-1693. doi: 10.1016/j.arthro.2021.02.002.
Septic arthritis is a devastating complication of anterior cruciate ligament (ACL) reconstruction, which can still occur in approximately 1% of patients despite appropriate intravenous antibiotic prophylaxis and other recommended preventative measures being undertaken. The infection is most likely secondary to the autograft becoming contaminated during harvest and preparation, introducing bacteria into the joint on insertion. Presoaking ACL grafts in 5 mg/mL vancomycin is a novel method developed to eradicate this bacterial contamination and is supported by compelling Level III evidence from multiple observational trials showing a dramatic reduction in infection rates without any evidence of increased graft failure. As such, it is time for this technique to become a universal recommendation? That said, as observational studies using a historical cohort as a comparator are at risk of various biases, Level I evidence is ultimately required for infection prophylaxis methods to be recognized as a universal recommendation in infection control guidelines. Consequently, future research endeavors on the "vancomycin wrap" should focus on randomized controlled trials, possibly nested within ACL registries.
感染性关节炎是前交叉韧带(ACL)重建的一种破坏性并发症,尽管采取了适当的静脉抗生素预防措施和其他推荐的预防措施,仍有约 1%的患者会发生这种感染。感染最有可能是由于移植物在采集和准备过程中被污染,在插入时将细菌引入关节。将 ACL 移植物浸泡在 5mg/mL 万古霉素中是一种新方法,旨在消除这种细菌污染,并且得到了多项观察性试验的 III 级证据的支持,这些试验表明,该方法可显著降低感染率,而没有任何证据表明移植物失败的风险增加。因此,现在是否应该将该技术作为普遍建议?话虽如此,由于使用历史队列作为对照的观察性研究存在各种偏倚的风险,因此,感染预防方法要被认为是感染控制指南中的普遍建议,最终需要 I 级证据。因此,“万古霉素包裹”的未来研究工作应侧重于随机对照试验,可能嵌套在 ACL 登记处内。